Significant Ownership of Quan Zhou

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Quan Zhou focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 1 identity field
Manager location
Central, Hong Kong

Significant Ownership of Quan Zhou

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CASI CASI Pharmaceuticals, Inc. Ordinary Shares, par value US$0.0001 per share 4.8% $754,405 992,638 0% Zhou Quan 30 Sep 2025

Schedules 13D/G Reported by Quan Zhou:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .